Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

Novavax, Inc. (NVAX)

-NasdaqGS
11.62 0.00(0.00%) Aug 28, 4:00PM EDT
Add to Portfolio
Prev Close:11.62
Open:11.36
Bid:10.20 x 100
Ask:11.60 x 100
1y Target Est:16.77
Beta:0.754144
Earnings Date:Nov 3 - Nov 9 (Est.)
Day's Range:11.28 - 11.71
52wk Range:3.92 - 15.01
Volume:3,788,309
Avg Vol (3m):4,614,990
Market Cap:3.13B
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAX 0.00%3.13B
MRKUp 0.76%155.96B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):80.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.38
Quarterly EPS Est (Sep-15) :-0.09
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback